Effect of an Ayurvedic Medicine NIA/DG/2020/01 and Telmisartan on High Blood Pressure

INTERVENTION: CONDITION: Health Condition 1: I10‐ Essential (primary) hypertension Health Condition 2: I10‐ Essential (primary) hypertension PRIMARY OUTCOME: Change in Blood Pressure from baseline at the end of 90 days ; ; Timepoint: Significant reduction in blood pressure at the end of 90 days from baseline ; ; ; SECONDARY OUTCOME: Changes in Subjective symptoms associated with hypertension from baseline at the end of 90 days ; Changes in Quality of Life score assessed by WHOQOL BREF questionnaire from baseline at the end of 90 days ; Safety of the interventions by monitoring adverse events & changes in laboratory parameters during the study period & at end of 90 days ; Timepoint: Improvement in subjective symptoms associated with hypertension at the end of 90 days. ; Improvement in Quality of Life score assessed by WHOQOL BREF questionnaire at the end of 90 days from baseline. ; Safety of the interventions assessed by adverse events & laboratory parameters at the end of 90 days ; INCLUSION CRITERIA: Patients belonging to either se Xbetween the age group 18 to 60 years. Patients having systolic blood pressure greater than equal to 140 upto 180 mm of Hg and diastolic blood pressure greater than 90 upto 110 mm of Hg as per 8th JNC criteria. Duration of disease will be 1 to 6 months Patients diagnosed with primary hypertension within the past si Xmonths will be regarded as newly diagnosed cases in this study.